Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer.
about
The framework of pathology: good laboratory practice by quantitative and molecular methods.The management of superficial bladder cancer.The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancerStaging and reporting of urothelial carcinoma of the urinary bladder.Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks.Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.Urothelial bladder carcinoma in young patients is characterized by a relatively good prognosisThe pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreementMcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological gradeRole of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetNovel therapeutic targets in bladder cancer: mutation and expression of FGF receptors.Bladder cancer: clinical and pathological profile.The optimal management of T1 high-grade bladder cancer.The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification.Pathology review impacts clinical management of patients with T1-T2 bladder cancerA Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis.Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro.Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.
P2860
Q30862047-FFF7B5AC-5D5A-4845-80F7-3E99988CC20FQ34135229-75FD1FB0-9E61-435C-9020-686AF536E764Q34452006-7566C730-A642-418E-8779-BF4B065C0D93Q34984796-122250EC-F6C7-4344-B4BC-E147194B2B0FQ35093186-6F1A3501-0A26-479F-A1FC-97548196CA97Q35586503-0CCEB78A-0A3A-47B8-A315-A8C274CB2CEFQ35586813-2DDA85CF-AF16-4CD8-90C6-56CC497B59DAQ35764916-E10B4504-3521-4640-8E87-168EAD9DE8D4Q36249221-EE88EE28-3E43-4314-AE9C-631CF0E25966Q36312232-54CE7229-887B-47E5-B0E2-5B1BB4016360Q36358049-E4D4D02C-7362-4C17-BE2B-A426E7701738Q36609412-E578F5EE-7F66-447B-9BD9-7123E4B61AD6Q36958930-1D4A8DC6-6B02-4D4B-B8DA-76EE1667D42FQ37074139-9E0AEF26-BE8A-496D-86CE-B1F3C115B53BQ37278983-F6FA1FDA-EB61-4908-B848-9A26FABF0D79Q37472570-DE322892-2B0A-4717-AA48-69323E9865A6Q37779813-84C2E570-480F-49C5-82D7-72FB55C39381Q38879980-C2F6FC6F-0E4C-4096-A766-4C042EF541CBQ39399826-BD587BE6-24AF-4AEC-A6B2-5C26ACC7CB1DQ39568069-D87C2F97-B0B4-4258-937C-4FBA1E6BA3A6Q42936872-B306856A-58CA-4468-B5DB-D476B158FBB1Q43924805-C2029B43-CF6C-4DEC-8728-C6554EDE9D05Q51996613-A6DEF912-EDE7-4B5D-967F-8B35025E5363Q52963664-CB514EB6-F1D1-4A19-AAD8-EC5A09F3CFFBQ53083086-EE612C65-6EDA-4800-ADD6-410250A99640Q54242629-2067E1CC-AFFB-4412-AFF8-A1037B059974
P2860
Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical significance of inter ...... of superficial bladder cancer.
@ast
Clinical significance of inter ...... of superficial bladder cancer.
@en
type
label
Clinical significance of inter ...... of superficial bladder cancer.
@ast
Clinical significance of inter ...... of superficial bladder cancer.
@en
prefLabel
Clinical significance of inter ...... of superficial bladder cancer.
@ast
Clinical significance of inter ...... of superficial bladder cancer.
@en
P2093
P2860
P1433
P1476
Clinical significance of inter ...... of superficial bladder cancer.
@en
P2093
Bannwart F
Knönagel H
Mihatsch MJ
P2860
P356
10.1046/J.1464-410X.2000.00356.X
P577
2000-01-01T00:00:00Z